BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37684564)

  • 1. Association between IL-10 gene polymorphisms (- 1082 A/G, -819 T/C, -592 A/C) and hepatocellular carcinoma: a meta-analysis and trial sequential analysis.
    Mei TTY; Aung HH; Tung WS; Naing C
    BMC Cancer; 2023 Sep; 23(1):842. PubMed ID: 37684564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of three interleukin 10 gene polymorphisms (- 1082 A > G, - 819 C > T, - 592 A > C) in the risk of chronic and aggressive periodontitis: a meta-analysis and trial sequential analysis.
    Wong HC; Ooi Y; Pulikkotil SJ; Naing C
    BMC Oral Health; 2018 Oct; 18(1):171. PubMed ID: 30348144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 9 (-1237 T/C, -1486 T/C) and the risk of gastric cancer: a meta-analysis of genetic association studies.
    Qyi YZ; Aung HH; Aye SN; Tung WS; Naing C
    BMC Cancer; 2023 Oct; 23(1):1027. PubMed ID: 37875868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-10 gene polymorphisms and hepatocellular carcinoma susceptibility: a meta-analysis.
    Wei YG; Liu F; Li B; Chen X; Ma Y; Yan LN; Wen TF; Xu MQ; Wang WT; Yang JY
    World J Gastroenterol; 2011 Sep; 17(34):3941-7. PubMed ID: 22025883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the association between five polymorphisms and risk of hepatocellular carcinoma: A meta-analysis.
    Yu JY; Hu F; Du W; Ma XL; Yuan K
    J Chin Med Assoc; 2017 Apr; 80(4):191-203. PubMed ID: 28188097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of interleukin-6 gene polymorphisms with the risk of hepatocellular carcinoma: An up-to-date meta-analysis.
    An PP; Feng LN; Zhang XX; Jin QL
    Medicine (Baltimore); 2020 Dec; 99(50):e23659. PubMed ID: 33327352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TNF-α, IL-1B and IL-10 polymorphisms and risk for hepatocellular carcinoma: a meta-analysis.
    Yang Y; Luo C; Feng R; Bi S
    J Cancer Res Clin Oncol; 2011 Jun; 137(6):947-52. PubMed ID: 21107607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between the Interleukin-10 -1082 G/A polymorphism and risk of hepatocellular carcinoma.
    Wang Y; Hu P
    Afr Health Sci; 2020 Mar; 20(1):351-358. PubMed ID: 33402922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.
    Li JF; Zheng EQ; Xie M
    Gene; 2019 Feb; 685():143-148. PubMed ID: 30403964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of IL-6 polymorphisms with hepatocellular carcinoma risk: evidences from a meta-analysis.
    Liu Y; Gao SJ; Du BX; Wang JJ
    Tumour Biol; 2014 Apr; 35(4):3551-61. PubMed ID: 24318992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between IL-1 family gene polymorphisms and colorectal cancer: A meta-analysis.
    Liu L; Zhai Z; Wang D; Ding Y; Chen X; Wang Q; Shu Z; Wu M; Chen L; He X; Fan D; Pan F; Xing M
    Gene; 2021 Feb; 769():145187. PubMed ID: 32998046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of three promoter polymorphisms in interleukin-10 gene with the risk for colorectal cancer and hepatocellular carcinoma: A meta-analysis.
    Shi YH; Zhao DM; Wang YF; Li X; Ji MR; Jiang DN; Xu BP; Zhou L; Lu CZ; Wang B
    Sci Rep; 2016 Aug; 6():30809. PubMed ID: 27489033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms of ALDH2 and ADH2 are not associated with risk of hepatocellular carcinoma among East Asians.
    Zhou D; Xiao L; Zhang Y; Xian J; Jiang J; Zong W; Huang Z; Yang Y
    Tumour Biol; 2012 Jun; 33(3):841-6. PubMed ID: 22231434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between IL-4 Polymorphisms and Risk of Liver Disease: An Updated Meta-Analysis.
    Wu Z; Qin W; Zeng J; Huang C; Lu Y; Li S
    Medicine (Baltimore); 2015 Sep; 94(35):e1435. PubMed ID: 26334904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-α 238 G/A polymorphism and risk of hepatocellular carcinoma: evidence from a meta-analysis.
    Cheng K; Zhao YJ; Liu L; Wan JJ
    Asian Pac J Cancer Prev; 2013; 14(5):3275-9. PubMed ID: 23803115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between hepatocellular carcinoma and tumor necrosis factor alpha polymorphisms in South Korea.
    Shin SP; Kim NK; Kim JH; Lee JH; Kim JO; Cho SH; Park H; Kim MN; Rim KS; Hwang SG
    World J Gastroenterol; 2015 Dec; 21(46):13064-72. PubMed ID: 26672513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. XPD Polymorphisms and Risk of Hepatocellular Carcinoma and Gastric Cancer: A Meta-Analysis.
    Zhou Q; Fu Y; Wen L; Deng Y; Chen J; Liu K
    Technol Cancer Res Treat; 2021; 20():1533033821990046. PubMed ID: 33517857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interleukin 10 -819C/T polymorphism and cancer risk: a HuGE review and meta-analysis of 73 studies including 15,942 cases and 22,336 controls.
    Yu Z; Liu Q; Huang C; Wu M; Li G
    OMICS; 2013 Apr; 17(4):200-14. PubMed ID: 23574339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of Cyclooxygenase-2 gene -765G > C (rs20417) and -1195G > A (rs689466) polymorphisms in gastric cancer: A systematic review and meta-analysis.
    Luo MX; Long BB; Li F; Zhang C; Pan MT; Huang YQ; Chen B
    Gene; 2019 Feb; 685():125-135. PubMed ID: 30391440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms of tumor necrosis factor-alpha and hepatocellular carcinoma risk: a HuGE systematic review and meta-analysis.
    Wei Y; Liu F; Li B; Chen X; Ma Y; Yan L; Wen T; Xu M; Wang W; Yang J
    Dig Dis Sci; 2011 Aug; 56(8):2227-36. PubMed ID: 21336601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.